Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Suspect Hepatitis C (HCV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Suspect Hepatitis C (HCV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Suspect Hepatitis C (HCV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 273 of 273 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Symptoms | Western Blot | Abbott Architect | Risk Categories | Vaccinated for Hepatitis A | Vaccinated for Hepatitis B | Vaccinated for Influenza within 60 days prior to phlebotomy | Subject Taking Vitamin B7 (Biotin) | Is Subject Taking a Multivitamin Supplement |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBP0000-BU900106672060613DD | Suspect Hepatitis C (HCV) | United States | Plasma | 1.00 | 4.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0000-A0900109701070219DD | Suspect Hepatitis C (HCV) | Serum | 0.50 | 9.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Hypokalemia, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Calcium acetate, Niacin, Clonazepam, Garlique, Oxycodone, Glipizide, Rosuvastatin, Insulin lispro, Sertraline, Insulin lantus, Sildenafil, Metoprolol | U/A | Yes 24-Nov-18 | No | No | |||||||||||||
| BBS0000-A0900109887062419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 17.00 | $150.00 | 66 Y | Female | Non-Hispanic | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Autoimmune hepatitis, Venous stasis dermatitis, Hypokalemia, Normocytic anemia, Hypertension, Thrombocytopenia, Rheumatoid arthritis | Enalapril, Folic acid, Furosemide, Hydrocortisone ointment, Protonix, Prednisone, Spironolactone, Thiamine | No | No | No | No | ||||||||||||||
| BBS0000-A0900110004072319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $150.00 | 65 Y | Female | Non-Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | NASH, Portal hypertension, HCC | Xanax, Prozac, Prevacid, Zofran, Pseudoephedrine, Acetaminophen, Aldactone | No | No | No | No | ||||||||||||||
| BBS0000-A0900110005081319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $150.00 | 68 Y | Female | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Ascites due to alcoholic cirrhosis, Anasarca, Edema, Cellulitis, Preglaucoma, Senile nuclear sclerosis, Diabetes type 2, Atrial fibrillation, Hypertension, Hyperlipidemia | Furosemide, Metoprolol succinate, Spironolactone, Ursodiol, Warfarin | No | No | No | No | ||||||||||||||
| BBS0000-A0900110006082119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Alcholic cirrhosis, Peptic ulcer disease, Esophageal varices, Anemia | Ferrous sulfate, Furosemide, Omeprazole, Propranolol, Spironolactone | No | No | No | No | ||||||||||||||
| BBS0000-A0900110007062419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Non-alcoholic fatty liver disease, Cholecystitis, Ulcerative colitis, Macrocytosis, Elevated TSH, Glaucoma, Sick sinus syndrome, A-fib, Hypertension, Arthritis, Tendonitis, Erectile dysfunction, Seborrheic keratosis, Patent foramen ovale | Allopurinol, Xanax, Norvasc, Eliquis, Alphagan, Vitamin D3, Cosopt, Vitamin D2, Glucosamine, Norco, Hydrocortisone, Xalatan, Magnesium, Purinethol, Mesalamine, Multi-Vitamin Injection, Omega 3, Potassium, Revatio | No | No | No | No | ||||||||||||||
| BBS0000-A0900111845071019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 9.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | NASH, Obstructive sleep apnea, Hyperlipidemia, Glaucoma, Cataracts, Diabetes type 2, Psoriatic arthritis, Psoriasis, Arthritis | Farxiga, Cymbalta, Neurontin, Amaryl, Cozaar, Glucophage, Cosentyx, Zocor | No | No | No | No | ||||||||||||||
| BBS0000-A0900111846082019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 20-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Cirrhois secondary to NASH, Hypothyroidism, Gastroesophageal reflux disease, Depression, Sinusitis, Hypertension, Diabetes, NAFLD, Hepatic enchphalopathy, Osteoarthritis left knee, Squamous cell carcinoma ear | Atarax, Lancets, Claritin-D, Diabetic pen needle, Xifaxan, Insulin aspart, Levothyroxine, Singulair, Zoloft, Hydrocortisone cream | Yes 4-Apr-18 | No | No | No | ||||||||||||||
| BBS0000-BD900410502030320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $150.00 | 36 Y | Female | Non-Hispanic | <-70C | 03-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | 2020-03-03 | None | No | No | No | No | No | |||||||||||
| BBS0000-BD900411410030520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 05-Mar-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965; Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Dark colored urine | $150.00 | Unknown | Stomach ulcers; Pre-diabetes | 2020-03-05 | Protonix, Aspirin | U/A | U/A | No | No | No | |||||||||||
| BBS0000-BD900411411031120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 11-Mar-20 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | 2020-03-11 | Genvoya | No | No | No | No | No | |||||||||||
| BBS0000-BD900419915082520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $150.00 | 33 Y | Male | Unknown | <-70C | 25-Aug-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | Jaundice | $150.00 | Unknown | None | 2020-08-25 | None | No | No | No | No | No | |||||||||||
| BBS0000-BD900420245082620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 26-Aug-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | None | 2020-08-26 | None | No | No | No | No | No | |||||||||||
| BBS0000-BD900426529121919DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 31 Y | Male | Non-Hispanic | <-70C | 19-Dec-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 66 U/L | ALT: 77 U/L 20-Nov-2019 | $150.00 | Unknown | None | 2019-12-19 | Descovy | No | No | No | No | Centrum | |||||||||||
| BBS0000-BD900426807031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 49 Y | Female | Non-Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | High blood pressure, HIV | 2020-03-10 | Complera, Amlodipine | No | No | Yes | No | No | |||||||||||
| BBS0000-BD900426808031120DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 47 Y | Male | Non-Hispanic | <-70C | 11-Mar-20 | Subject Risk Information | Current or former user of IV drugs; Exposure to HCV+ blood in jail in a fight | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | 2020-03-11 | None | U/A | U/A | No | No | Centrum | |||||||||||
| BBS0000-BD900426809031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 63 Y | Female | Non-Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | High blood pressure, Seizures | 2020-03-10 | Amlodipine besylate, Levetiracetam | No | No | Yes | No | Women's One-a-day, Vitamin D-2000 | |||||||||||
| BBS0000-BD900426810062920DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 67 Y | Female | Non-Hispanic | <-70C | 29-Jun-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Jaundice | $150.00 | Unknown | Diabetes | 2020-06-29 | Metformin | No | No | No | No | No | |||||||||||
| BBS0000-BD900426811062420DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 5.00 | $150.00 | 42 Y | Male | Non-Hispanic | <-70C | 24-Jun-20 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient | Primary Signs and Symptoms | Jaundice | $150.00 | Unknown | High blood pressure | 2020-06-24 | Minoxidil, Clonidine | No | No | No | No | No | |||||||||||
| BBS0000-BD900426812072320DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 23-Jul-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965; HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, COPD | 2020-07-23 | Genvoya, Xanax | No | No | No | No | Strovite, Vitamin B12 | |||||||||||
| BBS0000-BD900426813072320DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 23-Jul-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | 2020-07-23 | None | No | No | No | No | No | |||||||||||
| BBS0000-BD900426814072320DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Jul-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | 2020-07-23 | None | No | No | No | Yes | No | |||||||||||
| BBS0000-BU900106672060613DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 2.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0000-BU900376314030220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | $75.00 | 58 Y | Male | Non-Hispanic | <-70C | 02-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2020-03-02 | Ibuprofen | No | No | No | No | No | ||||||||||||
| BBS0000-BU900376315022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Dysphagia, Emphysema, History of seizures, Knowledge deficit, Tobacco user, At risk for falls | 2020-02-26 | Acetaminophen, Albuterol, Amlodipine, Aspirin, Atorvastatin, Cholecalciferol, Ibuprofen | U/A | U/A | U/A | U/A | U/A | |||||||||||
| BBS0000-BU900376316030220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 56 Y | Male | Non-Hispanic | <-70C | 02-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Cervical radiculopathy, Obesity | 2020-03-02 | None | U/A | U/A | U/A | U/A | U/A | |||||||||||
| BBS0000-BU900376317022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 69 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Hyperlipidemia, Hypertension, Tobacco user, Vitamin D deficiency | 2020-02-26 | Amlodipine, Atorvastatin, Ergocalciferol | U/A | U/A | U/A | U/A | U/A | |||||||||||
| BBS0000-BU900376318022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 67 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Congestive heart failure, Diabetes mellitus, Hypertension, Morbid obesity, Sleep apnea, Tobacco user, Acid reflux, At risk for falls | 2020-02-26 | Acetaminophen, Aspirin, Albuterol, Flovent, Atorvastatin, Bumetanide, Carvedilol, Gabapentin, Insulin glargine, Lidocaine, Losartan, Nitroglycerin, Pantoprazole, Polyethylene glycol | U/A | U/A | U/A | U/A | Calcium - Vitamin D / Multivitamin | |||||||||||
| BBS0000-BU900376319022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 61 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Heart failure, Asthma, Anemia, Chronic pain, Diabetes mellitus, End stage renal disease, Hypertension, Hyperparathyroidism, Ineffective airway clearance | 2020-02-26 | Acetaminophen, Aspirin, Albuterol, Atorvastatin, Benzonatate, Cholecalciferol, Sevelamer, Cinacalcet, Nifedipine, Epoetin alfa, Fexofenadine, Flovent, Omeprazole, Gabapentin, Levothyroxine, Lisinopril, Montelukast | U/A | U/A | U/A | U/A | Multivitamin brand U/A | |||||||||||
| BBS0000-BU900382503030520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 71 Y | Female | Non-Hispanic | <-70C | 05-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Arthritis, Lumbar radiculopathy, Diabetes mellitus, Hyperlipidemia, Hypertension, Sacroiliitis, Biceps tendinitis of the right shoulder | 2020-03-05 | Amlodipine, Atenolol, Hydrochlorothiazide, Lantus, Lidoderm | U/A | U/A | U/A | U/A | U/A | |||||||||||
| BBS0000-BU900382504030520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 59 Y | Female | Non-Hispanic | <-70C | 05-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Asthma, COPD, At risk for falls, HIV, Hyperlipidemia, Hypertension, Obesity, Tobacco user, Arthritis in wrist, Total self-care deficit, Long term current use of opiate analgesic | 2020-03-05 | Albuterol, Albuterol Ipratropium, Aspirin, Atorvastatin, Bictegravir-Emtricitabine-Tenofovir, Budesonide Formoterol, Advair Diskus, Robafen, Lidocaine topical, Mometasone nasal, Oxybutynin, Prednisone, Spiriva Handihaler, Zolpidem | No | No | No | No | Multivitamin with iron | |||||||||||
| BBS0000-BU900382505030920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 09-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Hypertension, Tobacco user, Hypokalemia, Schizophrenia | 2020-03-09 | Acetaminophen, Amlodipine, Benztropine, Docusate, Hydrochlorothiazide, Ibuprofen, Loxapine, Metformin, Metoprolol, Olanzapine, Pantoprazole, Pravastatin, Biotene Saliva Substitute | U/A | U/A | U/A | U/A | No | |||||||||||
| BBS0000-BU900382507030920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 09-Mar-20 | Subject Risk Information | HIV infected individual, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | HIV, Tobacco user | 2020-03-09 | Aspirin, Atorvastatin, Escitalopram, Fluticasone nasal | No | No | No | No | No | |||||||||||
| BBS0000-BU900382508030920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 23 Y | Male | Unknown | <-70C | 09-Mar-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $75.00 | Unknown | At risk for falls, Bipolar disorder, At high risk for violence, Severe depression, Bipolar with psychotic features, Polysubstance abuse, Tobacco user | 2020-03-09 | Naloxene | U/A | U/A | U/A | U/A | No | |||||||||||
| BBS0000-BU900382509031820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 73 Y | Male | Non-Hispanic | <-70C | 18-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2020-03-18 | None | U/A | U/A | U/A | U/A | U/A | |||||||||||
| BBS0000-BU900382510031820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 58 Y | Male | Non-Hispanic | <-70C | 18-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Obesity, Tobacco user, Hypertension, Cheek swelling - dental abcess, Facial cellulitis | 2020-03-18 | Acetaminophen-Oxycodone, Amoxicillin Clavulanate, Gabapentin | U/A | U/A | U/A | U/A | U/A | |||||||||||
| BBS0000-CC900107988061319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 82 U/L; ALT: 69 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | Guillain-Barre syndrome, Lyme disease, Multiple sclerosis, Myasthenia gravis, Peripheral arterial disease, Peripheral vascular disease, Raynaud's syndrome | Cyanocobalamin (vitamin B12), Ergocalciferol, Gabapentin, Magnesium hydroxide, Potassium acetate, Pregabalin | No | No | |||||||||||||
| BBS0000-CC900111838060419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $150.00 | 32 Y | Male | Hispanic | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | None | Dextran hypomellose, Polymyxin B Sulfate-Trimethoprim drops | No | No | ||||||||||||||
| BBS0000-CC900361037020420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | Female | Unknown | <-70C | 04-Feb-20 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $75.00 | Unknown | 2020-02-04 | No | No | No | No | Prenatal vitamin plus low iron | ||||||||||||||
| BBS0000-CC900361045010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 31 Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||
| BBS0000-CC900361047010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | ||||||||||||||||||||||||
| BBS0000-CF900107989070119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Enlarged liver | $150.00 | Unknown | Alcoholic liver disease, Autoimmune hepatitis, Decompensated cirrhosis | Calcium carbonate / Magnesium / Vitamin D3, Cyanocobalamin, Dexlansoprazole, Furosemide, Hydrocodone-acetaminophen, Levothyroxine, Lorazepam, Ondansetron, Propranolol, Rifaximin, Spironolactone | Yes Date of Vaccination: U/A | Yes Date of Vaccination: U/A | No | No | ||||||||||||
| BBS0000-CF900107990052919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $150.00 | 53 Y | Female | Unknown | <-70C | 29-May-19 | Subject Risk Information | N/A | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L; ALT: 47 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Thyroid disease | Aspirin, Famotidine, Levothyroxine | No | No | |||||||||||||
| BBS0000-CF900111828053019DD | Suspect Hepatitis C (HCV) | United States | Serum | 0.50 | 12.00 | $150.00 | 46 Y | Female | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 177 U/L; AST: 74 U/L; ALT: 126 U/L:Test Date 30-May-2019 | $150.00 | Unknown | Anxiety, Arthritis, Cataract, Diabetes mellitus, Gastroesophageal reflux disease, Gout, Hypertension, Myositis of left upper extremity, Obesity unspecified, Obstructive sleep apnea, Other chronic nonalcoholic liver disease, Post-operative nausea and vomiting, Allergies | Solu-Medrol, Trulicity, Pepcid, Ibuprofen, Basaglar KwikPen, Claritin, Metformin, Toprol XL, Pyridium, Prednisone, Rituxan, Januvia, Ultram, Triamcinolone | No | No | |||||||||||||
| BBS0000-CF900111839062619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $150.00 | 48 Y | Male | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 (1987) | Suspect HCV:Adult | Primary Signs and Symptoms | Enlarged liver | $150.00 | Unknown | Iron deficieny anemia, Splenomegaly, Hepatomegaly, NASH cirrhosis, Diabetes mellitus, Esophageal varices, Morbid obesity, Myocardial infarction, GI bleed | Lactulose, Loratadine, Metformin, Multivitamin, Propranolol, Sitagliptin, Zinc | U/A | U/A | No | Yes | ||||||||||||
| BBS0000-CF900364392012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $75.00 | 20 Y | Male | Hispanic | <-70C | 29-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 82 U/L; ALT: 103 U/L; ALP: 251 U/L | 29-Jan-2020 | $75.00 | Unknown | Autoimmune enteropathy | 2020-01-29 | Tacrolimus | Yes 8-Jul-05 | Yes 2000 & 2001 | No | No | Centrum | |||||||||||
| BBS0000-CF900364396012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $75.00 | 61 Y | Female | Hispanic | <-70C | 29-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes ALP: 140 U/L | 28-Jan-2020 | $75.00 | Unknown | Anemia, Chronic abdominal pain, Back and neck pain, Gastric ulcer, Duodenal ulcer, GERD, Methamphetamine abuse, Bipolar disorder, Depression, Benign pancreatic mass | 2020-01-29 | Acetaminophen, Ciprofloxacin, Duloxetine, Famotidine, Ferrous sulfate, Ondansetron | No | No | Yes | No | No | |||||||||||
| BBS0000-CF900364399012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $75.00 | 54 Y | Male | Non-Hispanic | <-70C | 29-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 50 U/L; ALT: 133 U/L; ALP: 147 U/L | 28-Jan-2020 | $75.00 | Unknown | Diabetes mellitus, Asthma, Sarcoidosis, COPD, Pneumothorax status post chest tube in December | 2020-01-29 | Albuterol, Azithromycin, Fluticasone, Insulin glargine, Ipratropium, Metformin, Nicotine polacrilex, Omeprazole, Prednisone | Yes | Yes | Yes | No | No | |||||||||||
| BBS0000-CF900364406012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 10.00 | $75.00 | 33 Y | Female | Unknown | <-70C | 29-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes ALT: 44 U/L | 29-Jan-2020 | $75.00 | Unknown | Obesity, Hypertension | 2020-01-29 | Ondansetron | No | No | No | No | No | |||||||||||
| BBS0000-CF900365885020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 36 Y | Female | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 38 U/L; ALP: 36 U/L | 5-Feb-2020 | $75.00 | Unknown | Lupus, Kidney disease, HFpEF (heart failure with preserved ejection fraction) | 2020-02-06 | Albuterol, Amlodipine, Bupropion, Cetirizine, Clonidine, Cyclobenzaprine, Diphenhydramine, Fluticasone-salmeterol, Gabapentin, Hydrocodone-acetaminophen, Hydroxychloroquine, Ibuprofen, Labetalol, Mupirocin ointment, Naproxen, Nifedipine, Promethazine, Sertraline, Triamcinolone ointment | No | No | No | No | No | |||||||||||
| BBS0000-CF900365886020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | $75.00 | 44 Y | Female | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after needle stick exposure to HCV positive blood in 2005 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Abnormal cytology smear of cervix, Complications of anesthesia, Chronic fatigue, Depression, Dysautonomia orthostatic hypotension syndrome, Wolff-Parkinson-White pattern, Raynoud's disease, Spina bifida occulta, Myopia, Narcolepsy without cataplexy, Advanced maternal age | 2020-02-05 | Cranberry fruit concentrate, Dextramphetamine, Garlic, Magnesium, Progesterone, Senna | Yes 22-Jun-05 | Yes U/A | No | No | Prenatal vitamin with iron and folate | ||||||||||||
| BBS0000-CF900365887020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | $75.00 | 56 Y | Female | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Congestive heart failure, Pulmonary embolism on coumadin, GERD, Hiatal hernia, Depression | 2020-02-06 | Bupropion, Escitalopram oxalate, Gabapentin, Hydrocodone-acetaminophen, Lamotrigine, Lorazepam, Morphine, Prednisone, Risperidone, Trazodone, Warfarin | Yes 13-Jun-05 | No | No | No | No | ||||||||||||
| BBS0000-CF900365891020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 1.00 | $75.00 | 25 Y | Female | Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after mucosal exposure to HCV positive blood | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2020-02-05 | Drospirenone and ethinyl estradiol | Yes 2002 | 2003 | Yes 1994 | 1998 | Yes | No | No | |||||||||||
| BBS0000-CF900365892020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 52 Y | Female | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after needle stick exposure to HCV positive blood in 1995 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Mixed hyperlipidemia, Dense breast tissue on mammogram, Vaginal atrophy, Dyspareunia due to medical condition in female | 2020-02-05 | Amoxicillin, Estradiol, Ondansetron | Yes | Yes U/A | No | No | No | |||||||||||
| BBS0000-CF900368910021020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 21 Y | Female | Hispanic | <-70C | 10-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L; ALT: 83 U/L 10-Feb-2020 | $75.00 | Unknown | Kidney disease | 2020-02-10 | Baclofen, Nuproxen, Norgestimate-Ethinyl Estradiol | No | No | No | No | No | |||||||||||
| BBS0000-CF900368911021120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 47 Y | Male | Unknown | <-70C | 11-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after needle stick exposure to HCV positive blood. In 2005 or 2006 splashed in eye with HCV infected blood. | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Essential hypertension, Erectile dysfunction, Hyperglyceridemia, Decreased libido, Excessive consumption of soda, Lower UTI, Hypogonalism in male, Class 2 obesity with alveolar hypoventilation without serious comorbidity, Prediabetes, Hyperinsulinemia, Obstructive sleep apnea | 2020-02-11 | Amlopidine, Lisinopril, Tadalafil | No | Yes in 1996 and 1997 | No | No | Centrum, One A Day for Men | |||||||||||
| BBS0000-CF900368912021320DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | $75.00 | 69 Y | Female | Non-Hispanic | <-70C | 13-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Atrial Fibrillation previously on Amiodarone, Status post ablation, Hypertension | 2020-02-13 | Aspirin, Atorvastatin, Diltiazem, Irbesartan, Lorazepam, Metoprolol tartrate, Nitroglycerin, Pantoprazole, Rivaroxaban, Sucralfate | No | No | Yes | No | No | ||||||||||||
| BBS0000-CF900368913021220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 44 Y | Male | Non-Hispanic | <-70C | 12-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Hypertension, Asthma, End stage renal disease, Insulin-dependent diabetes mellitus | 2020-02-12 | Albuterol HFA, Amlodipine, Atenolol, Beclomethasone, Sevelamer carbonate | No | No | No | No | No | |||||||||||
| BBS0000-CF900368917021320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 68 Y | Female | Unknown | <-70C | 13-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Delirium, COPD, Anemia, Frequent UTI | 2020-02-13 | Acetaminophen, Albuterol, Amoxicillin clavulanate, Aspirin, Baclofen, Cranberry fruit, Ferrous sulfate, Iron, Gabapentin, Ibuprofen, Lorazepam, Nortriptyline, Polyethylene glycol, Pyridoxine, Quetiapine, Temazepam | No | No | No | No | Centrum, Multivitamin with minerals | |||||||||||
| BBS0000-CF900368918021220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 62 Y | Male | Unknown | <-70C | 12-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Constipation, Benign prostatic hyperplasia, Osteomyelitis, Foley catheter dependent | 2020-02-12 | Acetaminophen, Ascorbic acid, Aspirin, Baclofen, Bisacodyl, Cefazolin sodium, Celecoxib, Cephalexin, Docusate sodium, Gabapentin, Hydromorphone, Methocarbamol, Morphine, Naloxone, Polyethylene glycol, Sulfamethoxazole/Trimethoprim, Tamsulosin | No | No | No | Yes | Theragran, Vitamin C | |||||||||||
| BBS0000-CF900368919021320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 13-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Hypertension, Cerebrovascular accident | 2020-02-13 | Aixaban, Diltiazem, Divalproex, Gabapentin, Hydrocodone-acetaminophen, Methocarbamol | No | No | No | No | Centrum | |||||||||||
| BBS0000-CF900368920021020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 31 Y | Female | Hispanic | <-70C | 10-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 42 U/L; ALT: 39 U/L 10-Feb-2020 | $75.00 | Unknown | Anxiety, Depression, History of Cerebrovascular accident with residual deficit, Hypertension, Keratoconus B/L, Pneumonia at age 8, Rape trauma syndrome | 2020-02-10 | Amlodipine, Dicyclomine, Erythromycin ophthalmic ointment, Famotidine, Flarex ophthalmic solution, Hydrochlorothiazide, Hydrocodone-acetaminophen, Hydrocodone, Ibuprofen, Omeprazole | No | No | No | No | No | |||||||||||
| BBS0000-CF900373248010620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $75.00 | 79 Y | Female | Unknown | <-70C | 06-Jan-20 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | 5-Jan-20 | $75.00 | Unknown | Atrial fibrillation on Xarelto, Recurrent breast cancer currently on chemo | 2020-01-06 | Acetaminophen, Azelastine, Calcium carbonate, Cetirizine, Diclofenac sodium, Everolimus, Exemestane, Fluticasone, Levothyroxine, Losartan, Magnesium oxide, Melatonin, Omeprazole, Oseltamivir, Ranitidine, Rivaroxaban, Toprol | No | No | Yes | No | Multivitamin tablet | ||||||||||
| BBS0000-CF900373249010620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $75.00 | 61 Y | Male | Unknown | <-70C | 06-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 175 U/L | 6-Jan-20 | $75.00 | Unknown | Crohn's disease, Gastrointestinal stromal tumor, Cholangitis status post colectomy | 2020-01-06 | Calcipotriene-Betamethasone, Ciprofloxacin ophthalmic solution, Desonide, Diclofenac, Hydrocortisone rectal cream, Ketoconazole, Lidocaine, Prednisolone acetate, Vedolizumab | No | Yes 20-Oct-15 | No | No | Yes | U/A | ||||||||||
| BBS0000-CF900373250010920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $75.00 | 57 Y | Female | Non-Hispanic | <-70C | 09-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Diabetes mellitus, Hypertension, Hypersensitivity lung disease, End stage renal disease on hemodialysis | 2020-01-09 | Amlodipine, Aspirin, Atorvastatin, Glipizide, Lisinopril | No | No | No | No | No | |||||||||||
| BBS0000-CF900373251010920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $75.00 | 49 Y | Female | Hispanic | <-70C | 09-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 218 U/L | 8-Jan-20 | $75.00 | Unknown | Diabetes mellitus type 2, Hypertension, Schizophrenia, End stage renal disease on hemodialysis | 2020-01-09 | Benazepril, Divalproex, Docusate sodium, Epoetin alfa, Haloperidol, Insulin glargine, Insulin lispro, Metoprolol succinate, Senna, Sevelamer carbonate, Simvastatin | Yes U/A | Yes U/A | No | No | Vitamin B complex, Vitamin C folate | ||||||||||
| BBS0000-CF900373252010720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $75.00 | 38 Y | Female | Non-Hispanic | <-70C | 07-Jan-20 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes AST: 32 U/L | ALP: 153 U/L | 6-Jan-20 | $75.00 | Unknown | Nonischemic dilated cardiomyopathy, Hypertension, Recent stroke, Diabetes mellitus type 2, Heart transplant | 2020-01-07 | Apixaban, Cholecalciferol, Cyclosporine, Gabapentin, Insulin glargine, Levothyroxine, Metoprolol, Mexiletine, Mycophenolate, Nystatin, Omeprazole, Prednisone, Trazodone, Valganciclovir | Yes U/A | Yes U/A | No | No | No | ||||||||||
| BBS0000-CF900373253010920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $75.00 | 57 Y | Male | Unknown | <-70C | 09-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 147 U/L | 8-Jan-20 | $75.00 | Unknown | Paraplegia at T5 level status post gunshot wound | 2020-01-09 | Albuterol, Amikacin, Apixaban, Ascorbate calcium, Atorvastatin, Azithromycin, Budesonide, Buprenorphine-Naloxone, Cephalexin, Cholestyramine, Ciprofloxacin, Clindamycin, Collagenase, Cyclobenzaprine, Daptomycin, Diclofenac sodium, Fluconazole, Fluticasone propionate, Gabapentin, Hydralazine, Ibuprofen, Insulin lispro, Loperamide, Meropenem, Metformin, Mometasone, Mupirocin ointment, Naloxone, Nystatin, Ondansetron, Oxycodone-acetaminophen, Pantoprazole, Promethazine, Senna, Sodium chloride, Sufl | No | No | No | No | Cyanocobalamin, Multivitamin | ||||||||||
| BBS0000-CF900373254010720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $75.00 | 45 Y | Male | Hispanic | <-70C | 07-Jan-20 | Subject Risk Information | Blood, blood component or organ transplant recepient prior to 1992 (1985) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 40 U/L | 6-Jan-20 | $75.00 | Unknown | Neuropathic pain, GERD, Chronic kidney disease | 2020-01-07 | Azathioprine, Metformin, Prednisone, Sodium bicarbonate, Tacrolimus, Tamsulosin | U/A | U/A | Yes | No | No | ||||||||||
| BBS0000-CF900376311030220DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | $75.00 | 58 Y | Female | Unknown | <-70C | 02-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Lumbar surgery | 2020-03-02 | Hydrocodone-acetaminophen, Ibuprofen, Ropinirole | No | No | No | No | No | ||||||||||||
| BBS0000-CF900385334030220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 41 Y | Female | Non-Hispanic | <-70C | 02-Mar-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 51 U/L 2-Mar-2020 | $75.00 | Unknown | Recurrent nephrolithiasis | 2020-03-02 | Albuterol, Alprazolam, Amlodipine, Cetirizine, Docusate sodium, Doxycycline, Fluticasone, Hydrocodone-acetaminophen, Losartan, Oxcarbazepine, Prednisone, Zolpidem | No | No | No | No | No | |||||||||||
| BBS0000-CF900406408061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 2.00 | $150.00 | 16 Y | Female | Hispanic | <-70C | 16-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Cholecystitis | 2020-06-16 | Ibuprofen | No | No | No | No | No | |||||||||||
| BBS0000-CF900406409061820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $150.00 | 16 Y | Male | Hispanic | <-70C | 18-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 80 U/L; ALT: 170 U/L | 18-Jun-2020 | $150.00 | Unknown | None | 2020-06-18 | None | Yes | Yes | No | No | No | |||||||||||
| BBS0000-CF900406410052720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $150.00 | 36 Y | Female | Non-Hispanic | <-70C | 27-May-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L | 27-May-2020 | $150.00 | Unknown | Hypertension, Ovarian cyst | 2020-05-27 | Atenolol, Hydrocodone acetaminophen, Ibuprofen, Losartan | No | No | No | No | No | |||||||||||
| BBS0000-CF900406411060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $150.00 | 52 Y | Female | Hispanic | <-70C | 09-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 139 U/L | 8-Jun-2020 | $150.00 | Unknown | Bilateral above the knee amputations, End stage renal disease on dialysis, Coronary artery disease, Hypertension, Diabetes mellitus, Cerebrovascular accident with mild left sided deficits | 2020-06-09 | Aspirin, Atorvastatin, Benazepril, Carvedilol, Clonidine, Clopidogrel, Docusate sodium, Erythromycin ophthalmic, Famotidine, Glipizide, Hydralazine, Isosorbide dinitrate, Isosorbide mononitrate, Loratadine, Metoclopramide, Metoprolol tartrate, Nifedipine, Nitroglycerin, Triamcinolone, Venlafaxine, Zinc sulfate | No | No | No | No | No | |||||||||||
| BBS0000-CF900406412061020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $150.00 | 65 Y | Female | Unknown | <-70C | 10-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 47 U/L; ALP: 316 U/L | 10-Jun-2020 | $150.00 | Unknown | Fibromyalgia, Hyperlipidemia, Diverticulitis | 2020-06-10 | Alprazolam, Aspirin, Atorvastatin, Escitalopram oxalate, Tramadol | No | No | No | No | No | |||||||||||
| BBS0000-CF900408140060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 1.00 | $150.00 | 46 Y | Female | Unknown | <-70C | 09-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L | 8-Jun-2020 | $150.00 | Unknown | Polysubstance abuse, Previous infection | 2020-06-09 | None | No | No | No | No | No | |||||||||||
| BBS0000-CF900409231062320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $150.00 | 12 Y | Male | Hispanic | <-70C | 23-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes AST: 776 IU/L; ALT: 980 IU/L; ALP: 672 IU/L 8-Jun-2020 | $150.00 | Unknown | Autism, Primary sclerosing cholangitis | 2020-06-23 | Acetaminophen, Clonazepam, Diphenhydramine, Famotidine, Fluocinolone, Fluticasone propionate, Hydrocortisone, Ketoconazole, Triamcinolone, Ursodiol, Vancomycin | Yes in 2008 & 2009 | Yes in 2007 & 2008 | No | No | Chewable multivitamin with iron and minerals | |||||||||||
| BBS0000-CF900409232062920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $150.00 | 14 Y | Female | Hispanic | <-70C | 29-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L; ALT: 91 U/L | 29-Jun-2020 | $150.00 | Unknown | Asthma, BMI ? 95% for her age | 2020-06-29 | Albuterol, Azithromycin, Ibuprofen, Penicillin V potassium, Prednisone | Yes in 2007 | Yes in 2006 | No | No | No | |||||||||||
| BBS0000-CF900409233063020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $150.00 | 11 Y | Male | Hispanic | <-70C | 30-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L | 30-Jun-2020 | $150.00 | Unknown | None | 2020-06-30 | None | Unknown | Unknown | No | No | No | |||||||||||
| BBS0000-CF900409234061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 6.00 | $150.00 | 45 Y | Male | Unknown | <-70C | 16-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | None | 2020-06-16 | Omeprazole | No | No | No | No | No | |||||||||||
| BBS0000-CF900413871062520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $150.00 | 15 Y | Male | Non-Hispanic | <-70C | 25-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 162 IU/L | 25-Jun-2020 | $150.00 | Unknown | None | 2020-06-25 | Clindamycin, Hydrocortisone | Yes in 2006, 2008 & 2009 | Yes in 2005 | No | No | No | |||||||||||
| BBS0000-CF900414583062920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $150.00 | 11 Y | Female | Hispanic | <-70C | 29-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 227 IU/L | 29-Jun-2020 | $150.00 | Unknown | None | 2020-06-29 | None | Unknown | Unknown | No | No | No | |||||||||||
| BBS0000-CF900415391060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $150.00 | 8 Y | Female | Hispanic | <-70C | 09-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 148 U/L | 8-Jun-2020 | $150.00 | Unknown | Asthma | 2020-06-09 | Albuterol, Nebu nebuliser solution | Unknown | Unknown | No | No | Probiotic gummies, Over the counter unknown name and brand | |||||||||||
| BBS0000-CF900415397061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $150.00 | 72 Y | Male | Non-Hispanic | <-70C | 16-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease on dialysis; Afibrillation on diltiazem | 2020-06-16 | Allopurinol, Aspirin, Calcium acetate, Diltiazem, Levetiracetam, Losartan, Metoprolol succinate, Pantoprazole | Yes in 2019 & 2020 | Yes in 2013 & 2016 | Yes unknown date | No | Folic acid / Vitamin B complex and C, Cholecalciferol | |||||||||||
| BBS0000-CF900415398061020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $150.00 | 15 Y | Male | Hispanic | <-70C | 10-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 201 U/L | 9-Jun-2020 | $150.00 | Unknown | None | 2020-06-10 | Clindamycin, Ibuprofen, Oxycodone, Polyethylene glycol | Yes | Yes | No | No | No | |||||||||||
| BBS0000-FH900365424122319DD | Suspect Hepatitis C (HCV) | United States | Serum | 7.00 | 20.00 | $150.00 | 45 Y | Male | Unknown | <-70C | 23-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Chronic kidney disease, Hypokalemia (older co-morbidities listed in chart) | 2019-12-16 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Heparin | No | No | Yes 2019-10-23 | No | No | |||||||||||
| BBS0000-FH900365893122419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 21.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 24-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-19 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Acetaminophen with codeine, Hydrocortisone, Isosorbide dinitrate, Allopurinol, Ketoconazole, Amiodaraone, Amlodipine | No | No | Yes 2019-10-13 | No | Dialyvite | |||||||||||
| BBS0000-FH900365933122419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 24-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-19 | Epogen, Hectorol, Heparin, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Insulin Lispro, Lactobacillus floranex, Ertapenem, Dificid, Gabapentin, Insulin lantus, Renvela | No | No | Yes 2019-11-12 | No | Vitamin B complex, C Folbee, Vitamin B | |||||||||||
| BBS0000-FH900365934121919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $150.00 | 73 Y | Female | Non-Hispanic | <-70C | 19-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-10 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Carvedilol, Estradiol, Eliquis, Pantoprazole, Losartan, Renvela, MiraLax, Sensipar, Simvastatin, Temazepam, Erlotinib | No | No | Yes 2019-09-19 | No | No | |||||||||||
| BBS0000-FH900376838120619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $75.00 | 46 Y | Male | Non-Hispanic | <-70C | 06-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Other disorders of plasma-protein metabolism, Postprocedural hypoparathyroidism (older co-morbidities listed in chart) | 2019-12-04 | Hectoral, Heparin, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Lisinopril, Aspirin, Metoprolol, Promethazine, Docusate sodium, Tramadol | No | No | No | No | No | |||||||||||
| BBS0005-AC900057148051312DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 53 U/L | 14 U/L | 7 U/L ALP | AST | ALT 6.4 g/dL | 3.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||
| BBS0005-AC900057149041012DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Fever / chills; Elevated LFTs | Positive | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 107 U/L | 173 U/L | 25 U/L ALP | AST | ALT 5.1 g/dL | 1.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||
| BBS0005-AC900064076091512DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 49 Y | Female | Unknown | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Jaundice; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 35 U/L | 7 U/L ALP | AST | ALT 6.9 g/dL | 2.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Sex worker | |||||||||||||
| BBS0005-AC900065317050613DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 35 Y | Female | Unknown | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Elevated LFTs | Positive | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 97 U/L | 27 U/L | 20 U/L ALP | AST | ALT 5.2 g/dL | 2.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners | |||||||||||||
| BBS0005-AC900065318032913DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 22 Y | Male | Unknown | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.4 mg/dL TBIL | DBIL 265 U/L | 31 U/L | 8 U/L ALP | AST | ALT 4.8 g/dL | 1.8 g/dL Protein | Albumin | Institutionalized population | |||||||||||||
| BBS0005-AC900069462100512DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 19 Y | Male | Unknown | <-70C | 05-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.6 mg/dL TBIL | DBIL 442 U/L | 42 U/L | 9 U/L ALP | AST | ALT 5.3 g/dL | 1.7 g/dL Protein | Albumin | Homosexual M | |||||||||||||
| BBS0005-AC900074789081912DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Fatigue; Nausea; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 3.6 mg/dL | 2.3 mg/dL TBIL | DBIL 132 U/L | 32 U/L | 6 U/L ALP | AST | ALT 3.8 g/dL | 1.6 g/dL Protein | Albumin | Institutionalized population | |||||||||||||
| BBS0005-BU900032895101812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 39 Y | Male | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Chills;Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 47 U/L | 15 U/L | 12 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Body punctures (Tattooing); Haemodialysis patient | |||||||||||||
| BBS0005-BU900032896080212DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 23 Y | Male | Non-Hispanic | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 54 U/L | 58 U/L | 41 U/L ALP | AST | ALT 8.3 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners | |||||||||||||
| BBS0005-BU900032903010713DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 33 U/L | 17 U/L | 11 U/L ALP | AST | ALT 8 g/dL | 4.1 g/dL Protein | Albumin | Hemolized | |||||||||||||
| BBS0005-BU900032906020413DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.6 mg/dL TBIL | DBIL 47 U/L | 19 U/L | 12 U/L ALP | AST | ALT 6.8 g/dL | 44 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||
| BBS0005-BU900032907021413DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 62 U/L | 24 U/L | 26 U/L ALP | AST | ALT 7.4 g/dL | 4.5 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||
| BBS0005-BU900036004013014DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia) | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 132 U/L | 28 U/L | 17 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||
| BBS0005-BU900036005092513DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | N/A | 1 mg/dL | 0.4 mg/dL TBIL | DBIL 116 U/L | 119 U/L | 52 U/L ALP | AST | ALT 9.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||
| BBS0005-BU900036007121113DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Chills | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 32 U/L | 19 U/L ALP | AST | ALT 7.7 g/dL | 4.3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0005-BU900036888031213DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Positive | 11.3 mg/dL | 0.6 mg/dL TBIL | DBIL 54 U/L | 13 U/L | 12 U/L ALP | AST | ALT 6.5 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmited diseases (STD); Multiple sex partners | |||||||||||||
| BBS0005-BU900036889111512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 0.6 mg/dL | 0.4 mg/dL TBIL | DBIL 58 U/L | 19 U/L | 9 U/L ALP | AST | ALT 4.6 g/dL | 2.8 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||
| BBS0005-BU900036891112312DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Elevated LFTs | N/A | 1.6 mg/dL | 1.1 mg/dL TBIL | DBIL 812 U/L | 71 U/L | 40 U/L ALP | AST | ALT 6.6 g/dL | 3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0005-BU900036900110512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 49 U/L | 15 U/L | 11 U/L ALP | AST | ALT 6.1 g/dL | 3.8 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||
| BBS0005-BU900042698120512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 41 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||
| BBS0005-BU900042703120712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine; Elevated LFTs | N/A | 0.8 mg/dL | 0.5 mg/dL TBIL | DBIL 66 U/L | 3245 U/L | 316 U/L ALP | AST | ALT 8.1 g/dL | 3.9 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Occupational contact with blood (Trained as medical assistant); Body punctures (Piercing, human bite); Household contacts of HBV or HCV infected person | |||||||||||||
| BBS0005-BU900050689122712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 71 U/L | 28 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing, human bite); Household contacts of HBVor HCV infected person | |||||||||||||
| BBS0005-BU900050690111612DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Fever / chills; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 84 U/L | 61 U/L | 9 U/L ALP | AST | ALT 9.1 g/dL | 5.5 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures (Piercing) | |||||||||||||
| BBS0005-BU900050691012813DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 17 U/L | 14 U/L ALP | AST | ALT 6.2 g/dL | 3.6 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Occupational contact (Medical or dental workers); Body punctures (Tattooing, piercing, human bite); Institutionalized population (Prisoners) | |||||||||||||
| BBS0005-BU900052406022812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.8 mg/dL | 0.4 mg/dL TBIL | DBIL 166 U/L | 194 U/L | 24 U/L ALP | AST | ALT 7.2 g/dL | 3.9 g/dL Protein | Albumin | Haemodialysis patient | |||||||||||||
| BBS0005-BU900052417061412DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 276 U/L | 50 U/L | 19 U/L ALP | AST | ALT 7.6 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| BBS0005-BU900057146031912DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.1 mg/dL | 0.4 mg/dL TBIL | DBIL 27 U/L | 11 U/L | 14 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| BBS0005-BU900057147032012DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 22 Y | Male | Non-Hispanic | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 1.3 mg/dL | 0.4 mg/dL TBIL | DBIL 49 U/L | 10 U/L | <6 U/L ALP | AST | ALT 8.2 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| BBS0005-BU900057174043013DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 42 Y | Female | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 63 U/L | 10 U/L | 17 U/L ALP | AST | ALT 6.1 g/dL | 4.2 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Acupuncture, piercing) | |||||||||||||
| BBS0005-BU900057176061013DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 32 Y | Male | Non-Hispanic | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.5 mg/dL TBIL | DBIL 65 U/L | 9 U/L | 8 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0005-BU900057177041713DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Chills; Elevated LFTs | N/A | 1.8 mg/dL | 0.9 mg/dL TBIL | DBIL 59 U/L | 86 U/L | 48 U/L ALP | AST | ALT 6.6 g/dL | 4.1 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0005-BU900064064041212DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 15 U/L | 8 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||
| BBS0005-BU900066340112513DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 87 U/L | 37 U/L | 22 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Intravenous drug user; Body punctures (Tattooing, piercing); Institutionalized population (Prisoners) | |||||||||||||
| BBS0005-BU900074796091012DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 47 U/L | 20 U/L | 15 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing) | |||||||||||||
| BBS0005-BU900074797091412DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 46 Y | Female | Non-Hispanic | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills;Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 66 U/L | 28 U/L | 13 U/L ALP | AST | ALT 7.8 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Dental workers); Body punctures (Acupuncture, tattooing) | |||||||||||||
| BBS0005-BU900079066090512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 83 U/L | 33 U/L | 12 U/L ALP | AST | ALT 8.8 g/dL | 5.1 g/dL Protein | Albumin | Haemodialysis patient; Household contacts of HBV or HCV infected person | |||||||||||||
| BBS0005-BU900079077100812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 36 Y | Female | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.4 mg/dL | 0.7 mg/dL TBIL | DBIL 138 U/L | 1323 U/L | 688 U/L ALP | AST | ALT 8.7 g/dL | 5.4 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing); | |||||||||||||
| BBS0005-BU900079079102212DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 28 Y | Female | Non-Hispanic | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Abdominal pains; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 14 U/L | 9 U/L ALP | AST | ALT 7.6 g/dL | 4.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0005-BU900079080091712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 31 Y | Male | Non-Hispanic | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains;Dark color urine; Elevated LFTs | N/A | 0.7 mg/dL | 0.5 mg/dL TBIL | DBIL 63 U/L | 276 U/L | 42 U/L ALP | AST | ALT 6.4 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| BBS0005-BV900066338083013DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Diarrhea;Elevated LFTs | Positive | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 67 U/L | 16 U/L | 10 U/L ALP | AST | ALT 8.2 g/dL | 4.9 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures | |||||||||||||
| BBS0005-BV900069486052113DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 41 Y | Male | Non-Hispanic | <-70C | 21-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 41 U/L | 15 U/L | <6 U/L ALP | AST | ALT 5.1 g/dL | 3.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M; Body punctures | |||||||||||||
| BBS0005-CC900022537061019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L: Test Date 10-Jun-2019 | $150.00 | Unknown | Congestive heart failure, Cerebrovascular accident, Cardiomyopathy 2° to substance abuse, Atrial fibrillaiton | Aspirin, Atorvastatin, Enoxaprin, Fluoxetine, Furosemide, Metoprolol tartrate, Warfarin | No | No | |||||||||||||
| BBS0005-CC900024128061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L; ALP: 364 U/L Test Date: 11-Jun-2019 | $150.00 | Unknown | Atrial fibrillation, Valve replacement, Pneumonia, Atrial septal defect, Cardiomyopathy, Congestive heart failure, Encounter for blood transfusion, Essential hypertension, Secondary biliary cirrhosis, Severe tricuspid valve insufficiency, Hypothyroidism | Amoxicillin, Aspirin, Bumetanide, Famotidine, Ferrous sulfate, Gabapentin, Levothyroxine, Magnesium chloride, Potassium chloride, Senna docusate, Spironolactone, Warfarin | U/A | U/A | |||||||||||||
| BBS0005-CC900027863061319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 64 Y | Male | Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 160 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | Diabetes Mellitus | None | U/A | U/A | |||||||||||||
| BBS0005-CC900027865061319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 19 Y | Male | Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Pediatric | Primary Signs and Symptoms | Elevated liver enzymes | AST: 85 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | None | Acetaminophen, Ibuprofen | U/A | U/A | |||||||||||||
| BBS0005-CC900027866061119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Small bowel obstruction, Arachnoiditis, Arthritis, Fracture of L1 vertebra, Herniation of intervertebral disc between L5 and S1, Retinal detachment, Urinary tract infection unresolved with antibiotics | Amitriptyline, Cyclobenzaprine, Hydrocodone acetaminophen, Ibuprofen, Levothyroxine, Mirabegron, Multivitamin, Omeprazole, Zonisamide | No | No | ||||||||||||||
| BBS0005-CC900031093061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 57 Y | Male | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Diabetes Mellitus, Osteomyelitis, Chronic right foot wound | Aspirin, Atorvastatin, Furosemide, Gabapentin, Glimepiride, Humalog, Tramadol, Insulin glargine, Ketorolac, Losartan, Omeprazole, Steglatro, Sulfamethoxazole trimethoprim, Tamsulosin | U/A | No | ||||||||||||||
| BBS0005-CC900031096060519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Male | Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L; ALT: 65 U/L: Test Date 5-Jun-2019 | $150.00 | Unknown | None | Ondansetron | No | No | |||||||||||||
| BBS0005-CC900032897080712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Fatigue; Nausea; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing) | |||||||||||||
| BBS0005-CC900037605061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Elevated liver enzymes | AST: 97 U/L; ALT: 65 U/L:Test Date 12-Jun-2019 | $150.00 | Unknown | Chronic kidney disease, Diabetes mellitus, Hypertension, Malignant neoplasm liver cancer | Ciproflxacin, Furosemide, Lactulose, Metformin, Xifaxan, Spironolactone | U/A | U/A | |||||||||||||
| BBS0005-CC900037606061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 0.50 | 10.00 | $150.00 | 25 Y | Female | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Long term hemodialysis patients | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Lupus, Congestive heart failure, Renal transplant, End-stage renal disease on dialysis, Cardiomyopathy Hypertension, Lupus nephritis | Amlodipine, Beclomethasone, Calcium acetate, Carvedilol, Clonidine, Sevelamer carbonate, Senna docusate, Hydrocodone acetaminophen, Levofloxacin, Lisinopril, Loratadine, Prednisone, Tacrolimus, Warfarin | YES | U/A | Yes | 2017 | ||||||||||||||
| BBS0005-CC900037607061019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 102 U/L; ALP: 1697 U/L: Test Date 10-Jun-2019 | $150.00 | Unknown | Arthritis, Bilateral lower extremity edema, Coronary artery disease, Cirrhosis, Diabetes mellitus, Encounter for blood transfusion, Gastrointestinal hemorrhage with hematemesis, Glaucoma, Hypertension, Myocardial infarction, Neuromyopathy | Maalox plus, Aspirin, Atorvastatin, Clotrimazole lotrimin, Diclofenac sodium, Ergocalciferol, Flonase, Lasix, Gabapentin, Robitussin, Atarax, Insulin glargine, Lactulose, Multivitamin, Mycostatin, Prilosec, Xifaxan, Gas-X, Spironolactone, Timoptic, Trazodone | U/A | Yes | 27-Feb-2018 | |||||||||||||
| BBS0005-CC900041238060519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 196 U/L; ALT: 52 U/L; ALP: 830 U/L: Test Date 4-Jun-2019 | $150.00 | Unknown | Colon cancer metastasized to liver | Docusate sodium, Hydromorphone, Spironolactone, Trazodone | No | No | |||||||||||||
| BBS0005-CC900041244061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine; Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 65 U/L; ALT: 155 U/L; ALP: 140 U/L:Test Date 11-Jun-2019 | $150.00 | Unknown | History of hepatitis B virus infection, Laryngopharyngeal reflux, Myocardial infarction | Aspirin, Ranitidine | U/A | U/A | |||||||||||||
| BBS0005-CC900041246061119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 56 Y | Male | Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Hypertension, GERD, Pneumonia, Seizure | Albuterol, Carvedilol, Famotidine, Fluoxetine, Hydralazine, Hydrocortisone, Hydroxyzine, Omeprazole, Quetiapine fumarate | YES | U/A | YES | U/A | ||||||||||||||
| BBS0005-CC900046340061019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 59 Y | Female | Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 93 U/L; ALT: 187 U/L; ALP: 247 U/L: Test Date 8-Jun-2019 | $150.00 | Unknown | Arthritis, Carpal tunnel syndrome, Disc degeneration, lumbar | None | No | No | |||||||||||||
| BBS0005-CC900069459051812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chlls; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 1 U/L | 6 U/L ALP | AST | ALT 6.1 g/dL | 3.9 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures | |||||||||||||
| BBS0005-CC900069460052912DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Liver cirrhosis; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chills; Dark color urine / light color feces; Elevated LFTs | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 52 U/L | 13 U/L | 10 U/L ALP | AST | ALT 7.6 g/dL | 4.2 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures | |||||||||||||
| BBS0005-CD900064062011513DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 20 Y | Female | Non-Hispanic | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 75 U/L | 29 U/L ALP | AST | ALT 8.6 g/dL | 4.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person (Mom) | |||||||||||||
| BBS0005-CF900022538062519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 307 U/L; ALT: 132 U/L | 25-Jun-19 | $150.00 | Unknown | Congestive heart failure, COPD, Hypertension, Cholangitis, Disorder of thyroid, Kidney disorder, Transient ischemic attack | Dicyclomine, Docusate sodium, Gabapentin, Levothyroxine, Lisinopril, Pantoprazole, Promethazine | No | U/A | No | No | |||||||||||
| BBS0005-CF900024129060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 57 Y | Female | Non-Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 218 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Absolute anemia, Chronic obstructive pulmonary disease, Congestive heart failure, Diabetes mellitus, Dialysis patient (non-compliant), End stage renal disease, GERD, Hypertension, Hypotension, Non-ST elevation myocardial infarction, Paroxysmal atrial fibrillation, Pulmonary hypertension, Umbilical hernia | Albuterol, Albuterol HFA, Aspirin, Atorvastatin, Dulcolax, Cetirizine, Cholecalciferol, Vitamin D3, Flexeril, Dicyclomine, Fluconazole, Folic acid, Combivent, Synthroid, Lidocaine, Lopressor, Proamatine, Protonix, Veltassa, Miralax, Lyrica, Senna, Renvela | No | No | |||||||||||||
| BBS0005-CF900027862062719DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 73 Y | Female | Non-Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L; ALP: 60 U/L | 27-Jun-19 | $150.00 | Unknown | Diabetes mellitus, Thyroid disorder, Dyslipidemia, Hypertension | Aspirin, Atenolol, Atorvastatin, Chlorhexidine, Glipizide, Hydrochlorothiazide, Ibuprofen, Insulin glargine, Insulin lispro, Liraglutide, Losartan, Metformin, Methimazole, Mupirocin ointment | U/A | U/A | U/A | U/A | |||||||||||
| BBS0005-CF900027864070319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 75 Y | Male | Non-Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 46 U/L | 2-Jul-19 | $150.00 | Unknown | Congestive heart failure, Arterial fibrillation, Multiple myeloma, Recent UTI | Acetaminophen, Acyclovir, Alfuzosin, Allopurinol, Apixaban, Benazepril, Cephalexin, Cholecalciferol, Vitamin D3, Cyanocobalamin, Finasteride, Insulin glargine, Insulin lispro, Magnesium oxide, Melatonin, Metoprolol succinate, Morphine, Pantoprazole, Polyethylene glycol, Senna, Sodium chloride, Sulfamethoxazole trimethoprim, Tamsulosin, Tramadol, Zinc sulfate | U/A | U/A | No | No | |||||||||||
| BBS0005-CF900027867053019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 35 Y | Male | Hispanic | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L; ALT: 52 U/L: Test Date 30-May-2019 | $150.00 | Unknown | Hypertension, Wolf parkinson white syndrome | Lorazepam | No | No | |||||||||||||
| BBS0005-CF900027868060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 51 Y | Male | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | ALT: 59 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Arthritis, Uncontrolled Diabetes Type 2 | Remeron, Nicoderm CQ | No | No | |||||||||||||
| BBS0005-CF900027869062619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 69 Y | Male | Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 64 U/L; ALT: 79 U/L; ALP: 634 U/L | 26-Jun-19 | $150.00 | Unknown | Pancreatic adenocarcinoma, Duodenal stricture, Obstructive jaundice | Acetaminophen, Dexamethasone, Ferrous sulfate, Ibuprofen, Insulin glargine, Ondansetron, Polyethylene, Potassium chloride, Prochlorperazine, Sertraline | No | No | No | No | |||||||||||
| BBS0005-CF900027870062519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 66 Y | Female | Non-Hispanic | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 171 U/L | 24-Jun-19 | $150.00 | Unknown | Hypertension, Diabetes mellitus, Anemia | Acetaminophen, Albuterol, Aprdra Solostar insulin, Baclofen, Carvediol, Docusate sodium, Omeprazole, Feburostat, Ferrous sulfate, Furosemide, Hydralazine, Hydrocodone-acetaminophen, Insuin aspart, Metoclopramide, Simvastatin, Spironolactone, Tramadol | U/A | U/A | No | No | |||||||||||
| BBS0005-CF900031091073019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 77 Y | Male | Hispanic | <-70C | 30-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 558 U/L; ALT: 355 U/L; ALP: 177 U/L | 29-Jul-2019 | $150.00 | Unknown | Diabetes mellitus, Hypersensitivity lung disease, Non-Hodgkin's Lymphoma after chemo, Mandible squamous cell cancer | Albuterol, Aspirin, Ibuprofen, Clonazepam, Finasteride, Fluoxetine | No | No | No | Yes | |||||||||||
| BBS0005-CF900031092071819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 70 Y | Male | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | 18-Jul-19 | $150.00 | Unknown | Hypertension, Gout, Anxiety | Allopurinol, Aspirin, Atorvastatin, Fluoxetine, Lisinopril, Terazosin | No | No | No | No | |||||||||||
| BBS0005-CF900031094072419DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 151 U/L | 24-Jul-19 | $150.00 | Unknown | Heart transplant, Lymphoma | Acyclovir, Allopurinol, Docusate sodium, Etoposide, Fluconazole, Gabapentin, Hydrocodone-acetaminophen, Insulin aspart, Levofloxacin, Loperamide, Magnesium oxide, Metoclopramide, Metoprolol succinate, Mirtazapine, Omeprazole, Ondansetron, Polyethylene glycol, Prednisone, Prochlorperazine, Senna, Sulfamethoxazole-trimethoprim, Tachrolimus | Yes Date of Vaccination: 14-May-15 | Yes U/A | No | No | |||||||||||
| BBS0005-CF900031095070219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 0.60 | 1.00 | $150.00 | 22 Y | Female | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 1-Jul-19 | $150.00 | Unknown | Spina bifida, Obesity, Steatosis of liver, Arthritis, Tonsillar hypertrophy, Paraplegia, Obstructive sleep apnea, Atopic dermatitis, Urinary retention, Juvenile plantar dermatosis, Cellulitis, Recurrent urinary tract infections / pyelonephritis, Chiari malformation type II, Adjustment disorder with depressed mood, Hydrocephalus, Myelomeningocele, Asthma | Acetaminophen, Epinephrine, Albuterol, Escitalopram oxalate, Fluticasone, Gabapentin, Lidocaine, Loperamide, Morphine, Naloxone, Nystatin, Ondansetron, Oxybutynin, Polyethylene glycol, Trazodone | No | No | No | No | |||||||||||
| BBS0005-CF900031097062619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 83 Y | Female | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 46 U/L; ALT: 58 U/L | 26-Jun-19 | $150.00 | Unknown | Multiple myeloma on chemo, Recent c.diff infection, Arthritis, Cholelithiasis, Breast cancer, Cataract, Diabetes mellitus, Fatty liver, Hypertension, Hyperlipidemia, Osteoarthritis, Obesity, Tinea pedis | Acyclovir, Aspirin, Atovaquone, Cyanocobalamin, Dexamethasone, Fidaxomicin, Gabapentin, Glucosamine sulfate, Ixazomib, Lenalidomide, Levothyroxine, Oxybutynin, Potassium chloride | No | No | U/A | No | |||||||||||
| BBS0005-CF900031098071719DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 31 Y | Female | Non-Hispanic | <-70C | 17-Jul-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 287 U/L; ALT: 69 U/L; ALP: 455 U/L | 17-Jul-19 | $150.00 | Unknown | Liver cirrhosis after liver transplant | Sirolimus, Tacrolimus | Yes U/A | Yes U/A | No | U/A | |||||||||||
| BBS0005-CF900037603052819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | BMI 36.0-36.9, Cerebrovascular accident, Coronary artery calcification seen on CAT scan, Thyroid disorder, Hypertension | Amlodipine, Atorvastatin, Aspirin, Isosorbide mononitrate, Levothyroxine, Topiramate | U/A | U/A | ||||||||||||||
| BBS0005-CF900037604070119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 48 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 59 U/L | 30-Jun-19 | $150.00 | Unknown | Diabetes mellitus type 1, Asthma, Gastroesophageal reflux without esophagitis, Hypertension, Kidney disease, Myocardial infarction | Acetaminophen, Albuterol, Amlodipine, Aspirin, Cyclobenzaprine, Diphenhydramine, Docusate sodium, Ferrous sulfate, Fluticasone, Glucagon, Glucose, Insulin aspart, Insulin Glargine, Lisinopril, Loratadine, Magnesium oxide, Metoclopramide, Metoprolol succinate, Nitroglycerin, Omeprazole, Ondansetron, Tiopropium bromide, Tolterodine, Vitamin B complex | No | No | No | No | |||||||||||
| BBS0005-CF900037608052919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Diabetes Mellitus, Vertigo, Hypertension, Arthritis, Asthma, Carpal tunnel syndrome, Diverticulitis, Fatigue, Fibromyalgia, Glaucoma, Hiatal hernia, Migraines, Obstructive sleep apnea, Patent foramen ovale, Premature ventricular contractions, Transient ischemic attack | Alprazolam, Budesonide, Clopidogrel, Fluoxetine, Insulin Glargine, Insulin Lispro, Magnesium oxide, Metoprolol, Semaglutide, Pravastatin, Zolpidem | U/A | U/A | ||||||||||||||
| BBS0005-CF900037609052919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice, Elevated liver enzymes | AST: 94 U/L; ALT: 85 U/L; ALP: 445 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Dysphonia, Dysphagia, Muscle tension dysphonia, Edema of larynx, Globus sensation, Laryngopharyngeal reflux, Reinke's edema of vocal folds, Tinnitus | Amlodipine, Aspirin, Benazepril, Omeprazole, Hydrochlorothiazide | Yes | Yes | |||||||||||||
| BBS0005-CF900037610053019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 50 Y | Male | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Umbilical hernia | None | Yes | 2009 | Yes | 2009 | ||||||||||||||
| BBS0005-CF900041239060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 63 Y | Female | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anxiety, Depression, Diabetes Mellitus type 2, Essential hypertension, Hyperlipidemia, Subclinical hypothyroidism | Aspirin, Cholecalciferol, Vitamin D3, Glipizide, Lisinopril, Metformin | U/A | Yes | 24-Apr-2014 | ||||||||||||||
| BBS0005-CF900041240052819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 45 U/L; ALT: 70 U/L: Test Date 28-May-2019 | $150.00 | Unknown | None | None | Yes | Yes | |||||||||||||
| BBS0005-CF900041241052819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 42 Y | Female | Hispanic | <-70C | 28-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 395 U/L; ALT: 182 U/L: Test Date 28-May-2019 | $150.00 | Unknown | Anemia, Depression, Endometriosis, Gallstones, Gastritis, Malignant melanoma of skin of left lower extremity, Uterine polyp | Albuterol, Clobetasol, Ibuprofen, Macrobid, Zofran ODT, Percocet, Miralax | No | Yes | 1997 & 1998 | |||||||||||||
| BBS0005-CF900041242060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 0.50 | 9.00 | $150.00 | 48 Y | Male | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; HIV infected individuals | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 286 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Asthma, Congestive heart failure, Cirrhosis, Diabetes mellitur, Dialysis patient, End stage renal disease, HIV, Hypertension, Legally blind, Liver disease, Myocardial infarction, Neuropathy, Renal disorder, Renal failure | Ziagen, Tylenol, Reyataz, Atorvastatin, B complex vitamin, Zyrtec, Sensipar, Plavix, Colace, Tivicay, Dorzolamide, Pepcid, Gabapentin, Norco, Insulin, Xalatan, Keppra, Lopressor, Zoloft, Norvir, Sevelamer, Dulcolax, Sodium chloride | Yes | Yes | |||||||||||||
| BBS0005-CF900041243060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 67 Y | Male | Non-Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Recurrent pleural effusion; Mass of upper lobe of right lung | None | No | No | ||||||||||||||
| BBS0005-CF900041245052919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Dark colored urine; Elevated liver enzymes | AST: 381 U/L; ALT: 326 U/L; ALP: 422 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Abscess left vulvar, Amputated great right toe, Anemia, Anxiety, Asthma, COPD, PTSD, Seizure, Septic shock, Suspicion of cervical cancer, Depression, Diabetes Mellitus, Head trauma, High cholesterol, Hypertension, Hypotension, Low potassium, MRSA, Necrotizing fasciitis, Neuropathy, Osteomyelitis, Postpartum depression | Ferrous sulfate, Gabapentin, Ibuprofen, Insulin Glargine, Insulin Lispro, Levofloxacin, Metformin, Nicotine, Nystatin, Phenytoin, Tramadol | Yes | Yes | |||||||||||||
| BBS0005-CF900045241053019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 60 Y | Male | Hispanic | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Obstructive sleep apnea, Heart failure with improved ejection fraction, ST-Elevation Myocardia Infarction, Anxiety, Arthritis, Obesity | Acetaminophen, Aspirin, Atorvastatin, Astelin, Coreg, Dextromethorphan, Zetia, Flonase, Ibuprofen, Zaditor, Eucerin, Lidocaine, Artificial Tears, Sodium chloride, Coenzyme Q10, Vitamins D2 & D3 | No | No | ||||||||||||||
| BBS0005-CF900046339053019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 82 Y | Female | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 58 U/L; ALP: 404 U/L: Test Date 30-May-2019 | $150.00 | Unknown | Aortic stenosis, Arthritis, Bilateral sensorineural hearing loss, Cardiac arrhythmia, Congestive heart failure, Essential hypertension, Hypothyroidism, Macular degeneration | Amiodarone, Amlodipine, Apixaban, Aspirin, Escitalopram oxalate, Furosemide, Levothyroxine, Melatonin, Metoprolol succinate, Pantoprazole, Potassium chloride, Valsartan | No | No | |||||||||||||
| BBS0005-CF900046341062619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Chiari malformation, Cholelithiasis | None | U/A | U/A | No | No | ||||||||||||
| BBS0005-CF900046342072919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 33 Y | Male | Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 305 U/L | 29-Jul-2019 | $150.00 | Unknown | Diabetes mellitus, End stage renal disease on dialysis, Ischemic bowel disease | Albuterol, Ascorbic acid, Aspirin, Bismuth subsalicylate, Buspirone, Calcium carbonate, Carvedilol, Cholecalciferol, Cinacalcet, Epoetin alfa-epbx, Gabapentin, Heparin, Hydrocortisone, Hydromorphone, Hydroxyzine, Insulin glargine, Insulin lispro, Levothyroxine, Lidocaine, Methocarbamol, Midodrine, Mirtazapine, Ondansetron, Oxycodone-acetaminophen, Pantoprazole, Piperacillin-Tazobactum, Polyethylene glycol, Prednisone, Sensipar, Sertraline, Sevelamer carbonate, Sodium chloride, Sulfamethoxazole, | U/A | Yes U/A | No | Yes | |||||||||||
| BBS0005-CF900069991091919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 19-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 45 U/L | 19-Sep-19 | $150.00 | Unknown | Cirrhosis, Left sided breast cancer, Status post knee replacement | Diclofenac sodium gel, Furosemide, Multivitamin calcium-iron-min, Propanolol, Spironolactone | No | Yes 2016 | No | No | ||||||||||||
| BBS0005-DI900036168112613DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 26-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 87 U/L | 13 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.7 g/dL Protein | Albumin | Multiple sex partners; Household contacts of HBV or HCV infected person | ||||||||||||||
| BBS0005-DI900036169112013DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 20-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 54 U/L | 15 U/L | 6 U/L ALP | AST | ALT 5.9 g/dL | 3.4 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person | ||||||||||||||
| BBS0005-DI900036170111313DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 115 U/L | 13 U/L | <6 U/L ALP | AST | ALT 6 g/dL | 3.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person; Confirmed HCV 1a | ||||||||||||||
| BBS0005-DI900036177111913DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 19-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Fever / chills | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 59 U/L | 28 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures | ||||||||||||||
| BBS0005-DI900054746071513DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 66 U/L | 9 U/L | <6 U/L ALP | AST | ALT 7.4 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Piercing); Institutionalized population | ||||||||||||||
| BBS0005-DI900054754071513DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 49 U/L | 21 U/L | 8 U/L ALP | AST | ALT 7.1 g/dL | 4 g/dL Protein | Albumin | Multiple sex partners; Institutionalized population | ||||||||||||||
| BBS0005-DI900061420071913DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 27 Y | Male | Non-Hispanic | <-70C | 19-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 37 U/L | 21 U/L | 12 U/L ALP | AST | ALT 7.6 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Institutionalized population | ||||||||||||||
| BBS0005-DI900061421072613DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 26-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 99 U/L | 85 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Sex worker; Body punctures; Institutionalized population | ||||||||||||||
| BBS0005-DI900061422073013DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 74 Y | Female | Non-Hispanic | <-70C | 30-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 69 U/L | 66 U/L | 38 U/L ALP | AST | ALT 8 g/dL | 4.2 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing); Transplant / transfusion of unscreened blood or blood products (Prior to 1992) | ||||||||||||||
| BBS0005-DI900061431073113DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 42 U/L | 15 U/L | 12 U/L ALP | AST | ALT 7.4 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Doctor in Cuba); Transfusion of unscreened blood or blood products (In 1993 in Cuba) | ||||||||||||||
| BBS0005-DI900066901073113DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 53 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Elevated LFTs | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 51 U/L | 43 U/L | 25 U/L ALP | AST | ALT 7.9 g/dL | 4.2 g/dL Protein | Albumin | Intravenous drug user (used reusable needles); Occutpational contact with blood (Medical or dental worker - needlestick in 1992); Household contact with HBV infected person | ||||||||||||||
| BBS0005-DI900066904080813DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 08-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 63 U/L | 14 U/L | 6 U/L ALP | AST | ALT 7.5 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Institutionalized population | ||||||||||||||
| BBS0005-DI900066905080913DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 77 Y | Female | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 80 U/L | 22 U/L | 23 U/L ALP | AST | ALT 7.9 g/dL | 4.7 g/dL Protein | Albumin | Occupational contact with blood (Retired nurse); Transplant / transfusion of unscreened blood or blood products (prior to 1992) | ||||||||||||||
| BBS0005-DI900066906080913DD | Suspect Hepatitis C (HCV) | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 19 U/L | 6 U/L ALP | AST | ALT 7.4 g/dL | 4.2 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | ||||||||||||||
| BBS0005-FC900041697102413DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 28 Y | Male | Non-Hispanic | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 77 U/L | 18 U/L | 10 U/L ALP | AST | ALT 6.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||
| BBS0005-FC900041698102913DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 41 Y | Female | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 86 U/L | 9 U/L | 6 U/L ALP | AST | ALT 7.2 g/dL | 3.7 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||
| BBS0005-FC900041699102913DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea; Abdominal pain | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 97 U/L | 14 U/L | 8 U/L ALP | AST | ALT 7.8 g/dL | 4.2 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||
| BBS0005-FI900032899091012DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 51 Y | Female | Unknown | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 96 U/L | 120 U/L | 117 U/L ALP | AST | ALT 7.1 g/dL | 4.2 g/dL Protein | Albumin | Body punctures; Transplant / tranfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||
| BBS0005-FI900054745112012DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 22 Y | Female | Non-Hispanic | <-70C | 20-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 1.3 mg/dL | 0.3 mg/dL TBIL | DBIL 48 U/L | 13 U/L | <6 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| BBS0005-FI900066336052913DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 37 Y | Male | Non-Hispanic | <-70C | 29-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea;Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 45 U/L | 31 U/L | 11 U/L ALP | AST | ALT 7.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M | |||||||||||||
| BBS0005-FI900069490061913DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 40 Y | Female | Non-Hispanic | <-70C | 19-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 44 U/L | 20 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures; Transplant / transfusion of blood or blood products (prior to 1992) | |||||||||||||
| DSP3800-AC900057148051312DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 53 U/L | 14 U/L | 7 U/L ALP | AST | ALT 6.4 g/dL | 3.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||
| DSP3800-AC900057149041012DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Fever / chills; Elevated LFTs | Positive | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 107 U/L | 173 U/L | 25 U/L ALP | AST | ALT 5.1 g/dL | 1.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||
| DSP3800-AC900064076091512DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 49 Y | Female | Unknown | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Jaundice; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 35 U/L | 7 U/L ALP | AST | ALT 6.9 g/dL | 2.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Sex worker | |||||||||||||
| DSP3800-AC900064077051913DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 20 Y | Female | Unknown | <-70C | 19-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 3.8 mg/dL | 2.6 mg/dL TBIL | DBIL 188 U/L | 186 U/L | 72 U/L ALP | AST | ALT 5.3 g/dL | 2.3 g/dL Protein | Albumin | Multiple sex partners | |||||||||||||
| DSP3800-AC900065316032613DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 50 Y | Male | Unknown | <-70C | 26-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Dark color urine / light color feces; Elevated LFTs | N/A | 1.9 mg/dL | 1.3 mg/dL TBIL | DBIL 257 U/L | 68 U/L | <6 U/L ALP | AST | ALT 4.6 g/dL | 1.4 g/dL Protein | Albumin | Transplant / transfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||
| DSP3800-AC900065317050613DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 35 Y | Female | Unknown | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Elevated LFTs | Positive | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 97 U/L | 27 U/L | 20 U/L ALP | AST | ALT 5.2 g/dL | 2.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners | |||||||||||||
| DSP3800-AC900065318032913DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 22 Y | Male | Unknown | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.4 mg/dL TBIL | DBIL 265 U/L | 31 U/L | 8 U/L ALP | AST | ALT 4.8 g/dL | 1.8 g/dL Protein | Albumin | Institutionalized population | |||||||||||||
| DSP3800-AC900069458092512DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 38 Y | Male | Unknown | <-70C | 25-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Weight loss; Fatigue; Dark color urine / light color feces; Elevated LFTs | N/A | 8.2 mg/dL | 5.7 mg/dL TBIL | DBIL 87 U/L | 102 U/L | 44 U/L ALP | AST | ALT 5.4 g/dL | 1.3 g/dL Protein | Albumin | Multiple sex partners | |||||||||||||
| DSP3800-AC900074789081912DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Fatigue; Nausea; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 3.6 mg/dL | 2.3 mg/dL TBIL | DBIL 132 U/L | 32 U/L | 6 U/L ALP | AST | ALT 3.8 g/dL | 1.6 g/dL Protein | Albumin | Institutionalized population | |||||||||||||
| DSP3800-BU900032895101812DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 39 Y | Male | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Chills;Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 47 U/L | 15 U/L | 12 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Body punctures (Tattooing); Haemodialysis patient | |||||||||||||
| DSP3800-BU900032896080212DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 1.00 | $150.00 | 23 Y | Male | Non-Hispanic | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 54 U/L | 58 U/L | 41 U/L ALP | AST | ALT 8.3 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners | |||||||||||||
| DSP3800-BU900032903010713DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.1 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 33 U/L | 17 U/L | 11 U/L ALP | AST | ALT 8 g/dL | 4.1 g/dL Protein | Albumin | Hemolized | |||||||||||||
| DSP3800-BU900032906020413DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.6 mg/dL TBIL | DBIL 47 U/L | 19 U/L | 12 U/L ALP | AST | ALT 6.8 g/dL | 44 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||
| DSP3800-BU900032907021413DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 62 U/L | 24 U/L | 26 U/L ALP | AST | ALT 7.4 g/dL | 4.5 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||
| DSP3800-BU900036004013014DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia) | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 132 U/L | 28 U/L | 17 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||
| DSP3800-BU900036005092513DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | N/A | 1 mg/dL | 0.4 mg/dL TBIL | DBIL 116 U/L | 119 U/L | 52 U/L ALP | AST | ALT 9.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||
| DSP3800-BU900036006111313DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 1.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia) | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 11 U/L | 6 U/L ALP | AST | ALT 7 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M | |||||||||||||
| DSP3800-BU900036007121113DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Chills | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 32 U/L | 19 U/L ALP | AST | ALT 7.7 g/dL | 4.3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-BU900036008122313DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 30 Y | Male | Non-Hispanic | <-70C | 23-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 66 U/L | 21 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 5 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900036888031213DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Positive | 11.3 mg/dL | 0.6 mg/dL TBIL | DBIL 54 U/L | 13 U/L | 12 U/L ALP | AST | ALT 6.5 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmited diseases (STD); Multiple sex partners | |||||||||||||
| DSP3800-BU900036889111512DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 0.6 mg/dL | 0.4 mg/dL TBIL | DBIL 58 U/L | 19 U/L | 9 U/L ALP | AST | ALT 4.6 g/dL | 2.8 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||
| DSP3800-BU900036890102512DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 23 Y | Female | Non-Hispanic | <-70C | 25-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 5.8 mg/dL | 3.9 mg/dL TBIL | DBIL 126 U/L | 414 U/L | 144 U/L ALP | AST | ALT 9.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-BU900036891112312DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Elevated LFTs | N/A | 1.6 mg/dL | 1.1 mg/dL TBIL | DBIL 812 U/L | 71 U/L | 40 U/L ALP | AST | ALT 6.6 g/dL | 3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-BU900036900110512DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 49 U/L | 15 U/L | 11 U/L ALP | AST | ALT 6.1 g/dL | 3.8 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900042698120512DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 41 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900042703120712DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine; Elevated LFTs | N/A | 0.8 mg/dL | 0.5 mg/dL TBIL | DBIL 66 U/L | 3245 U/L | 316 U/L ALP | AST | ALT 8.1 g/dL | 3.9 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Occupational contact with blood (Trained as medical assistant); Body punctures (Piercing, human bite); Household contacts of HBV or HCV infected person | |||||||||||||
| DSP3800-BU900050689122712DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 71 U/L | 28 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing, human bite); Household contacts of HBVor HCV infected person | |||||||||||||
| DSP3800-BU900050690111612DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Fever / chills; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 84 U/L | 61 U/L | 9 U/L ALP | AST | ALT 9.1 g/dL | 5.5 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures (Piercing) | |||||||||||||
| DSP3800-BU900050691012813DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 17 U/L | 14 U/L ALP | AST | ALT 6.2 g/dL | 3.6 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Occupational contact (Medical or dental workers); Body punctures (Tattooing, piercing, human bite); Institutionalized population (Prisoners) | |||||||||||||
| DSP3800-BU900052406022812DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.8 mg/dL | 0.4 mg/dL TBIL | DBIL 166 U/L | 194 U/L | 24 U/L ALP | AST | ALT 7.2 g/dL | 3.9 g/dL Protein | Albumin | Haemodialysis patient | |||||||||||||
| DSP3800-BU900052417061412DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 276 U/L | 50 U/L | 19 U/L ALP | AST | ALT 7.6 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900054744110612DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 06-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.7 mg/dL | 0.8 mg/dL TBIL | DBIL 52 U/L | 70 U/L | 19 U/L ALP | AST | ALT 6.8 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Piercing); Haemodialysis patient | |||||||||||||
| DSP3800-BU900057146031912DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.1 mg/dL | 0.4 mg/dL TBIL | DBIL 27 U/L | 11 U/L | 14 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900057147032012DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 22 Y | Male | Non-Hispanic | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 1.3 mg/dL | 0.4 mg/dL TBIL | DBIL 49 U/L | 10 U/L | <6 U/L ALP | AST | ALT 8.2 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900057174043013DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 42 Y | Female | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 63 U/L | 10 U/L | 17 U/L ALP | AST | ALT 6.1 g/dL | 4.2 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Acupuncture, piercing) | |||||||||||||
| DSP3800-BU900057176061013DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 32 Y | Male | Non-Hispanic | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.5 mg/dL TBIL | DBIL 65 U/L | 9 U/L | 8 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-BU900057177041713DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Chills; Elevated LFTs | N/A | 1.8 mg/dL | 0.9 mg/dL TBIL | DBIL 59 U/L | 86 U/L | 48 U/L ALP | AST | ALT 6.6 g/dL | 4.1 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-BU900064064041212DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 15 U/L | 8 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||
| DSP3800-BU900066340112513DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 87 U/L | 37 U/L | 22 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Intravenous drug user; Body punctures (Tattooing, piercing); Institutionalized population (Prisoners) | |||||||||||||
| DSP3800-BU900074796091012DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 47 U/L | 20 U/L | 15 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing) | |||||||||||||
| DSP3800-BU900074797091412DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 46 Y | Female | Non-Hispanic | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills;Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 66 U/L | 28 U/L | 13 U/L ALP | AST | ALT 7.8 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Dental workers); Body punctures (Acupuncture, tattooing) | |||||||||||||
| DSP3800-BU900074799090612DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 1.00 | $150.00 | 23 Y | Male | Non-Hispanic | <-70C | 06-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 2.9 mg/dL | 0.9 mg/dL TBIL | DBIL 85 U/L | 121 U/L | 40 U/L ALP | AST | ALT 8.6 g/dL | 50 g/dL Protein | Albumin | Homosexual M | |||||||||||||
| DSP3800-BU900079066090512DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 83 U/L | 33 U/L | 12 U/L ALP | AST | ALT 8.8 g/dL | 5.1 g/dL Protein | Albumin | Haemodialysis patient; Household contacts of HBV or HCV infected person | |||||||||||||
| DSP3800-BU900079077100812DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 36 Y | Female | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.4 mg/dL | 0.7 mg/dL TBIL | DBIL 138 U/L | 1323 U/L | 688 U/L ALP | AST | ALT 8.7 g/dL | 5.4 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing); | |||||||||||||
| DSP3800-BU900079079102212DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 28 Y | Female | Non-Hispanic | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Abdominal pains; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 14 U/L | 9 U/L ALP | AST | ALT 7.6 g/dL | 4.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-BU900079080091712DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 31 Y | Male | Non-Hispanic | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains;Dark color urine; Elevated LFTs | N/A | 0.7 mg/dL | 0.5 mg/dL TBIL | DBIL 63 U/L | 276 U/L | 42 U/L ALP | AST | ALT 6.4 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||
| DSP3800-BV900066338083013DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 1.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Diarrhea;Elevated LFTs | Positive | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 67 U/L | 16 U/L | 10 U/L ALP | AST | ALT 8.2 g/dL | 4.9 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures | |||||||||||||
| DSP3800-BV900069485050913DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 1.00 | $150.00 | 40 Y | Male | Non-Hispanic | <-70C | 09-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 84 U/L | 29 U/L | 42 U/L ALP | AST | ALT 7.9 g/dL | 4.5 g/dL Protein | Albumin | Body punctures; Homosexual M | |||||||||||||
| DSP3800-CC900032897080712DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Fatigue; Nausea; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing) | |||||||||||||
| DSP3800-CC900069459051812DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chlls; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 1 U/L | 6 U/L ALP | AST | ALT 6.1 g/dL | 3.9 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures | |||||||||||||
| DSP3800-CC900069460052912DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Liver cirrhosis; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chills; Dark color urine / light color feces; Elevated LFTs | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 52 U/L | 13 U/L | 10 U/L ALP | AST | ALT 7.6 g/dL | 4.2 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures | |||||||||||||
| DSP3800-CD900064062011513DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 20 Y | Female | Non-Hispanic | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 75 U/L | 29 U/L ALP | AST | ALT 8.6 g/dL | 4.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person (Mom) | |||||||||||||
| DSP3800-DI900036168112613DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 26-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 87 U/L | 13 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.7 g/dL Protein | Albumin | Multiple sex partners; Household contacts of HBV or HCV infected person | ||||||||||||||
| DSP3800-DI900036169112013DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 20-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 54 U/L | 15 U/L | 6 U/L ALP | AST | ALT 5.9 g/dL | 3.4 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person | ||||||||||||||
| DSP3800-DI900036170111313DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 115 U/L | 13 U/L | <6 U/L ALP | AST | ALT 6 g/dL | 3.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person; Confirmed HCV 1a | ||||||||||||||
| DSP3800-DI900036177111913DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 19-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Fever / chills | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 59 U/L | 28 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures | ||||||||||||||
| DSP3800-DI900054746071513DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 66 U/L | 9 U/L | <6 U/L ALP | AST | ALT 7.4 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Piercing); Institutionalized population | ||||||||||||||
| DSP3800-DI900054754071513DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 49 U/L | 21 U/L | 8 U/L ALP | AST | ALT 7.1 g/dL | 4 g/dL Protein | Albumin | Multiple sex partners; Institutionalized population | ||||||||||||||
| DSP3800-DI900061420071913DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 27 Y | Male | Non-Hispanic | <-70C | 19-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 37 U/L | 21 U/L | 12 U/L ALP | AST | ALT 7.6 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Institutionalized population | ||||||||||||||
| DSP3800-DI900061421072613DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 26-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 99 U/L | 85 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Sex worker; Body punctures; Institutionalized population | ||||||||||||||
| DSP3800-DI900061422073013DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 74 Y | Female | Non-Hispanic | <-70C | 30-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 69 U/L | 66 U/L | 38 U/L ALP | AST | ALT 8 g/dL | 4.2 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing); Transplant / transfusion of unscreened blood or blood products (Prior to 1992) | ||||||||||||||
| DSP3800-DI900061431073113DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 42 U/L | 15 U/L | 12 U/L ALP | AST | ALT 7.4 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Doctor in Cuba); Transfusion of unscreened blood or blood products (In 1993 in Cuba) | ||||||||||||||
| DSP3800-DI900066901073113DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 53 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Elevated LFTs | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 51 U/L | 43 U/L | 25 U/L ALP | AST | ALT 7.9 g/dL | 4.2 g/dL Protein | Albumin | Intravenous drug user (used reusable needles); Occutpational contact with blood (Medical or dental worker - needlestick in 1992); Household contact with HBV infected person | ||||||||||||||
| DSP3800-DI900066904080813DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 08-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 63 U/L | 14 U/L | 6 U/L ALP | AST | ALT 7.5 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Institutionalized population | ||||||||||||||
| DSP3800-DI900066905080913DD | Suspect Hepatitis C (HCV) | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 77 Y | Female | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 80 U/L | 22 U/L | 23 U/L ALP | AST | ALT 7.9 g/dL | 4.7 g/dL Protein | Albumin | Occupational contact with blood (Retired nurse); Transplant / transfusion of unscreened blood or blood products (prior to 1992) | ||||||||||||||
| DSP3800-FC900041697102413DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 28 Y | Male | Non-Hispanic | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 77 U/L | 18 U/L | 10 U/L ALP | AST | ALT 6.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||
| DSP3800-FC900041698102913DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 41 Y | Female | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 86 U/L | 9 U/L | 6 U/L ALP | AST | ALT 7.2 g/dL | 3.7 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||
| DSP3800-FC900041699102913DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea; Abdominal pain | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 97 U/L | 14 U/L | 8 U/L ALP | AST | ALT 7.8 g/dL | 4.2 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||
| DSP3800-FI900032899091012DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 51 Y | Female | Unknown | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 96 U/L | 120 U/L | 117 U/L ALP | AST | ALT 7.1 g/dL | 4.2 g/dL Protein | Albumin | Body punctures; Transplant / tranfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||
| DSP3800-FI900054745112012DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 22 Y | Female | Non-Hispanic | <-70C | 20-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 1.3 mg/dL | 0.3 mg/dL TBIL | DBIL 48 U/L | 13 U/L | <6 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||
| DSP3800-FI900069490061913DD | Suspect Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 40 Y | Female | Non-Hispanic | <-70C | 19-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 44 U/L | 20 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures; Transplant / transfusion of blood or blood products (prior to 1992) |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.